Nucleic acid molecule comprising asymmetrically modified ITR for improving expression rate of inserted gene, and use thereof
Described herein is a nucleic acid molecule including an asymmetrically modified inverted terminal repeat (ITR). An AAV vector including the nucleic acid molecule has advantages of increased productivity and expression efficiency of a transgene, and decreased genotoxicity, by having an asymmetric IT...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
28.05.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Described herein is a nucleic acid molecule including an asymmetrically modified inverted terminal repeat (ITR). An AAV vector including the nucleic acid molecule has advantages of increased productivity and expression efficiency of a transgene, and decreased genotoxicity, by having an asymmetric ITR in which any one of two ITRs is modified. Also, described herein is are compositions and vectors. |
---|---|
Bibliography: | Application Number: US202318190590 |